Mumbai-listed lab group Thyrocare has presented a five-year expansion plan that should take the company from 7 to 25 labs and from 1,200 to 5,000 service franchises by 2020. According to targets, sales will be up 20% to Rs300cr (US$45m) in 2016 and should hit Rs1,000cr (US$150m) by 2020.